Skip to main content
. 2022 Apr 10;14(8):1910. doi: 10.3390/cancers14081910

Table 2.

List of GEP NEN patient tumor samples used for patient-derived xenograft (PDX) development.

Patient Tumor ID Number Classification of Tumor WHO
Terminology
Differentiation Tumor Grade Ki67 (%) Establishment of PDX
PNET459 Pancreatic NET NET Grade 2 Well differentiated Intermediate 7 no
PNET560 Pancreatic NET NET Grade 2 Well differentiated Intermediate 8.4 no
PNET1164 Pancreatic NET NET Grade 2 Well differentiated Intermediate 13 no
SBNET1063 Small bowel NET NET Grade 3 Well differentiated High 80 no
NEC913 Ampullary NEC NEC, small and large-cell types Poorly differentiated High 80–90 yes
NEC1452 Rectal NEC NEC, large-cell type Poorly differentiated High 80–90 yes